➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Boehringer Ingelheim
Johnson and Johnson
Dow
McKinsey

Last Updated: August 2, 2021

DrugPatentWatch Database Preview

HALOPERIDOL DECANOATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Haloperidol Decanoate patents expire, and what generic alternatives are available?

Haloperidol Decanoate is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Somerset Theraps Llc, Teva Pharms Usa, West-ward Pharms Int, and Zydus Pharms. and is included in ten NDAs.

The generic ingredient in HALOPERIDOL DECANOATE is haloperidol decanoate. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Haloperidol Decanoate

A generic version of HALOPERIDOL DECANOATE was approved as haloperidol decanoate by FRESENIUS KABI USA on December 19th, 1997.

  Free Forever Trial

Drug patent expirations by year for HALOPERIDOL DECANOATE
Drug Prices for HALOPERIDOL DECANOATE

See drug prices for HALOPERIDOL DECANOATE

Drug Sales Revenue Trends for HALOPERIDOL DECANOATE

See drug sales revenues for HALOPERIDOL DECANOATE

Recent Clinical Trials for HALOPERIDOL DECANOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Case Western Reserve UniversityPhase 3
National Institutes of Health (NIH)Phase 3
University of North Carolina, Chapel HillPhase 4

See all HALOPERIDOL DECANOATE clinical trials

Pharmacology for HALOPERIDOL DECANOATE

US Patents and Regulatory Information for HALOPERIDOL DECANOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 074893-001 Dec 19, 1997 AO RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Zydus Pharms HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 211180-002 Oct 22, 2019 AO RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Mylan Labs Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075440-001 Feb 28, 2000 AO RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Gland Pharma Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 205241-002 May 12, 2017 AO RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Somerset Theraps Llc HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 209101-002 Jul 3, 2018 AO RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Mylan Labs Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075440-002 Feb 28, 2000 AO RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
West-ward Pharms Int HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075305-001 Sep 28, 1998 AO RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Boehringer Ingelheim
Johnson and Johnson
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.